Representing Kansas bioscience companies and research institutions
Home About KansasBio Membership Center Bioscience News Contact KansasBio
Information Resources Education & Training Networking & Collaboration Business & Investment


Up-to-the minute latest news in the biotechnology sector and from biotech companies in Kansas and around the world

  KansasBio photos  


Biotechnology Headlines from PR Newswire

Phase 3 DECISION Trial of NEXAVAR (sorafenib) in Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Cancer Refractory to Radioactive Iodine Published in The Lancet
Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2014 On April 29, 2014
SYLVANT™ (siltuximab) Receives FDA Approval to Treat Multicentric Castleman's Disease (MCD)
PTC Therapeutics to Present at Upcoming Investor Conferences
Acumed® introduces new Polarus® 3 Solution to treat proximal humerus fractures
CheckIssuing joins the Pharmaceutical Marketing Research Group
Lupin Appoints Theresa Stevens as Chief Corporate Development Officer
Binimetinib Continues To Advance In Clinical Development
Traveling Poses a Unique Set of Challenges for People with Blindness
Society for Clinical Research Sites Launches the Site Advocacy Group Initiative
Eravacycline's Improvements in Efficacy and Delivery Over Competitors will Drive Uptake for the Treatment of Gram-Negative Infections due to Multidrug-Resistant Enterobacteriaceae
Liventa Bioscience Responds To Lawsuit
MiMedx at SAWC Spring 2014: Multiple Studies And Clinical Experience Demonstrate Clinical And Cost Effectiveness Of EpiFix Allograft For Treatment Of Hard-to-Heal Wounds
PerceptiMed Founder Jacobs To Speak At Bio2Device Group Event
Lupin Inks Strategic Joint Venture Agreement with Yoshindo Inc.
Dotmatics Showcases Collaborative Project Tracking and Management Tool at Bio-IT World
WIRB-Copernicus Group's Chief Compliance Officer to Discuss Potential Impact of Corporate Consolidation on Human Research Protection Program Accreditation at 2014 AAHRPP Annual Conference
Generex Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations at ASCO 2014 Annual Meeting
Multi-Channel Pipettor QC Trends 2014 Market Research Report
AG Mednet Announces First Clinical Trial Quality Control Software for QIBA Imaging Protocol Compliance
Brandwidth Solutions Garners Four DxMA Creative Communications Awards for Clients
InterMune To Release First Quarter Financial Results On May 1
HemoShear Enters into R&D Collaboration with Medivir
Synthetic Biologics' Reports Preclinical Data to Support Clinical Development of Novel Pertussis Therapeutic
OncoGenex Announces Fast Track Designation Granted for Custirsen in Combination with Cabazitaxel/Prednisone as Second-line Chemotherapy in Phase 3 AFFINITY Trial of Men with Metastatic Castrate-Resistant Prostate Cancer
Surefire Medical's Groundbreaking COSY Clinical Trial Results Presented at ECIO: Is Coiling Prior to Radioembolization Still Necessary in Minimally Invasive Treatment of Liver Cancer?
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2014 Financial Results
Luminex Corporation Announces Norovirus as a Launch Menu Assay for its New Sample-to-Answer System, ARIES™
Amgen's First Quarter 2014 Revenues Increased 7 Percent To $4.5 Billion
RXi Pharmaceuticals Enters into Financing Facility with Lincoln Park Capital
Southern Research Institute Develops Novel Screening Capability For Discovery Of Therapeutics To Address Highly Pathogenic Agents
Organogenesis to Present New Apligraf® and Dermagraft® Data at the Symposium on Advanced Wound Care and Wound Healing Society Annual Meeting
Octapharma Funds Observational Treatment Registry Study to Examine the Long Term Effects of Donor Specific Antibodies on Renal Transplant Recipients
Jonathan Hodgson Joins Putnam Associates as Principal
The Global Biosimilars Pipeline Has Expanded by Over 40 Percent in the Last 12 Months
Avalanche Biotechnologies Secures $55 Million in Oversubscribed Series B Financing
Boston Scientific Begins Clinical Trial of ACUITY™ X4 LV Pacing Leads and RELIANCE™ 4-FRONT ICD Leads
Z Trim Expands Distribution Network
Bioject Inc. Adds To Its Global Distribution Network
Guardant Health Announces $30 Million Series B Financing Led By Khosla Ventures
NeuroPhage Discovers GAIM-changing Molecules to Combat Alzheimer's Disease and Other Neurodegenerative Disorders
AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C
MiMedx Files Lawsuit Against Liventa, Medline, And Musculoskeletal Transplant Foundation
Union MedTech and Rex Bionics to Exhibit at Master Investor 2014 Conference
AMRI to Announce First Quarter Results
Imprimis Pharmaceuticals' Go Dropless™ Cataract Surgery Formulations to be Presented in Two Sessions at the 2014 American Society of Cataract and Refractive Surgery (ASCRS) Annual Symposium & Congress
WuXi PharmaTech Schedules First-Quarter 2014 Earnings Release
Ambit Biosciences to Announce First Quarter 2014 Financial Results
United Therapeutics Corporation To Announce First Quarter 2014 Financial Results Before Market Open On Tuesday, April 29, 2014

< Prev Next >
PR Newswire - United Business Media

Kansas Bioscience Association

© 2004 Kansas Bioscience Organization (KansasBio). All rights reserved.